D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 93 Citations 33,382 496 World Ranking 5111 National Ranking 2872

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Alzheimer's disease
  • Disease

Victor L. Villemagne mainly investigates Alzheimer's disease, Dementia, Pathology, Pittsburgh compound B and Internal medicine. The various areas that Victor L. Villemagne examines in his Alzheimer's disease study include Positron emission tomography, Neuroimaging, Neuroscience and Cognitive decline. His Dementia research is multidisciplinary, incorporating perspectives in Magnetic resonance imaging, Episodic memory, Clinical psychology, Apolipoprotein E and Cerebellar cortex.

His Pathology research includes themes of Neocortex and Posterior cingulate. Victor L. Villemagne focuses mostly in the field of Pittsburgh compound B, narrowing it down to matters related to Atrophy and, in some cases, Asymptomatic. His biological study spans a wide range of topics, including Endocrinology, Oncology and Cardiology.

His most cited work include:

  • Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. (1210 citations)
  • Imaging beta-amyloid burden in aging and dementia. (920 citations)
  • Imaging beta-amyloid burden in aging and dementia. (920 citations)

What are the main themes of his work throughout his whole career to date?

Victor L. Villemagne mostly deals with Internal medicine, Disease, Alzheimer's disease, Pathology and Dementia. His Internal medicine study incorporates themes from Endocrinology, Cognition and Oncology. His Alzheimer's disease research focuses on Pittsburgh compound B in particular.

His Pathology study frequently links to related topics such as In vivo. Victor L. Villemagne combines subjects such as Neuroimaging and Cohort with his study of Dementia. His studies in Cognitive decline integrate themes in fields like Gerontology and Neuropsychology.

He most often published in these fields:

  • Internal medicine (35.77%)
  • Disease (32.73%)
  • Alzheimer's disease (33.94%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (35.77%)
  • Disease (32.73%)
  • Alzheimer's disease (33.94%)

In recent papers he was focusing on the following fields of study:

His main research concerns Internal medicine, Disease, Alzheimer's disease, Dementia and Cognitive decline. His Internal medicine study incorporates themes from Endocrinology, Cognition and Oncology. Disease is the subject of his research, which falls under Pathology.

His study explores the link between Pathology and topics such as White matter that cross with problems in Diffusion MRI. His research investigates the link between Alzheimer's disease and topics such as Neuroscience that cross with problems in Neurodegeneration. The Positron emission tomography study combines topics in areas such as Magnetic resonance imaging and Florbetaben.

Between 2016 and 2021, his most popular works were:

  • High performance plasma amyloid-β biomarkers for Alzheimer’s disease (497 citations)
  • Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions. (153 citations)
  • Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions. (153 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Alzheimer's disease
  • Disease

Victor L. Villemagne mainly focuses on Alzheimer's disease, Internal medicine, Disease, Cognitive decline and Apolipoprotein E. The various areas that he examines in his Alzheimer's disease study include Amyloid beta, Dementia, Biomarker and Positron emission tomography, Neuroscience. The study incorporates disciplines such as Magnetic resonance imaging, Florbetaben, 18F-florbetaben and Pathology in addition to Positron emission tomography.

His Internal medicine study integrates concerns from other disciplines, such as Endocrinology, Cognition, Episodic memory and Oncology. His Disease research is multidisciplinary, relying on both Surgery, Dopaminergic, Cerebrospinal fluid and Gerontology. His work is dedicated to discovering how Cognitive decline, Cohort are connected with Ageing and other disciplines.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Victor L. Villemagne;Samantha Burnham;Pierrick Bourgeat;Belinda M. Brown.
Lancet Neurology (2013)

1461 Citations

Imaging beta-amyloid burden in aging and dementia.

Christopher C Rowe;Steven Ng;Uwe Ackermann;Sylvia Gong.
Neurology (2007)

1156 Citations

Activation of memory circuits during cue-elicited cocaine craving

Steven Grant;Edythe D. London;David B. Newlin;Victor L. Villemagne.
Proceedings of the National Academy of Sciences of the United States of America (1996)

1116 Citations

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

Christopher C Rowe;Kathryn A Ellis;Kathryn A Ellis;Miroslava Rimajova;Pierrick Bourgeat.
Neurobiology of Aging (2010)

949 Citations

β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

Kerryn Elizabeth Pike;Gregory Raymond Savage;Victor L Villemagne;Steven Ng.
Brain (2007)

857 Citations

Longitudinal Assessment of Aβ and Cognition in Aging and Alzheimer Disease

Victor L Villemagne;Kerryn E Pike;Gaël Chételat;Kathryn A Ellis.
Annals of Neurology (2011)

790 Citations

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

Kathryn A Ellis;Ashley I Bush;David Darby;Daniela De Fazio.
International Psychogeriatrics (2009)

734 Citations

Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

Christopher C Rowe;Uwe Ackerman;William Browne;Rachel S Mulligan.
Lancet Neurology (2008)

673 Citations

Reduced Striatal Dopamine Transporter Density in Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomography Studies with [11C]WIN-35,428

Una D. McCann;Dean F. Wong;Fuji Yokoi;Victor Villemagne.
The Journal of Neuroscience (1998)

659 Citations

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

Akinori Nakamura;Naoki Kaneko;Victor L Villemagne;Takashi Kato.
Nature (2018)

649 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Victor L. Villemagne

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 292

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 256

Reisa A. Sperling

Reisa A. Sperling

Brigham and Women's Hospital

Publications: 211

William J. Jagust

William J. Jagust

Helen Wills Neuroscience Institute

Publications: 210

Ralph N. Martins

Ralph N. Martins

Edith Cowan University

Publications: 178

Clifford R. Jack

Clifford R. Jack

Mayo Clinic

Publications: 172

Ronald C. Petersen

Ronald C. Petersen

Mayo Clinic

Publications: 162

Keith A. Johnson

Keith A. Johnson

Harvard University

Publications: 151

Gil D. Rabinovici

Gil D. Rabinovici

University of California, San Francisco

Publications: 145

Philip Scheltens

Philip Scheltens

Vrije Universiteit Amsterdam

Publications: 136

John C. Morris

John C. Morris

Washington University in St. Louis

Publications: 136

David S. Knopman

David S. Knopman

Mayo Clinic

Publications: 126

Agneta Nordberg

Agneta Nordberg

Karolinska University Hospital

Publications: 124

Val J. Lowe

Val J. Lowe

Mayo Clinic

Publications: 118

William E. Klunk

William E. Klunk

University of Pittsburgh

Publications: 116

Michael W. Weiner

Michael W. Weiner

University of California, San Francisco

Publications: 114

Trending Scientists

Todd E. Clark

Todd E. Clark

Federal Reserve Bank of Cleveland

Stanislav Molchanov

Stanislav Molchanov

University of North Carolina at Charlotte

Sherryl Lee Lorraine Scott

Sherryl Lee Lorraine Scott

Blackberry (United States)

Keh-Chih Hwang

Keh-Chih Hwang

Tsinghua University

Xavier Domènech

Xavier Domènech

Autonomous University of Barcelona

Maria J. Climent

Maria J. Climent

Universitat Politècnica de València

Hiroshi Miyasaka

Hiroshi Miyasaka

Osaka University

Andrew J. Gooday

Andrew J. Gooday

National Oceanography Centre

Eva S. Lindström

Eva S. Lindström

Uppsala University

Robert J. C. Gilbert

Robert J. C. Gilbert

University of Oxford

Viswanath Kiron

Viswanath Kiron

Nord University

Thomas R. Sutter

Thomas R. Sutter

University of Memphis

Andrew S. Brierley

Andrew S. Brierley

University of St Andrews

Pierre Druilhe

Pierre Druilhe

Institut Pasteur

C. Wayne Smith

C. Wayne Smith

Baylor College of Medicine

Jerry P. Nolan

Jerry P. Nolan

University of Warwick

Something went wrong. Please try again later.